The FDA issued a complete response letter regarding AbbVie’s biologics license application for trenibotulinumtoxinE, a ...

The regulator has sent a complete response letter (CRL) to AbbVie for trenibotulinumtoxinE (TrenibotE), a follow-up to its ...

Revance Therapeutics: The primary challenger with its long-lasting alternative, Daxxify. While smaller than AbbVie, they are ...

AbbVie said on Thursday the U.S. Food and Drug Administration has declined to approve its experimental wrinkle treatment, ...

AbbVie (NYSE: ABBV) today announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Biologics License Application (BLA) for ...

The FDA has doled out two manufacturing-related complete response letters (CRLs), slamming the brakes on prospective ...

The CDC reported that three individuals were hospitalized with botulism-type symptoms in May and June following self-injection of botulinum toxin they purchased online for cosmetic use. The case ...

AbbVie received a Complete Response Letter (CRL) from the FDA for its Biologics License Application (BLA) for ...

Add Yahoo as a preferred source to see more of our stories on Google. One mom is speaking out amid an ongoing investigation into an infant botulism outbreak that has led to a nationwide infant formula ...

A Kentucky mom is reeling after her 4-month-old baby girl was hospitalized with infant botulism after she consumed a formula brand that has since been recalled nationwide. "I mean, you just feel ...

At least one Big Apple resident was among 10 people hospitalized with “severe” illness in the US after injecting Botox bought from unlicensed sources through social media this year, officials said ...